Skip to main content
Caplight Logo









Signum Surgical

Signum Surgical

Private
IrelandHealthcare & Life Scienceshttps://www.signumsurgical.com/

Last Round

Series A

Extension

Sep 20, 2022

Total Funding Raised

$9.64M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Signum Surgical is a medical technology company that develops minimally invasive solutions for the treatment of colorectal conditions, specifically anal fistula.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceanal fistulacolorectal surgerybioabsorbable implantmedtechsurgical implantproctologygastroenterologyfistula plugsurgical interventiontissue ingrowthb2b medical

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Signum Surgical Comparables

Compare Signum Surgical with similar companies based on industry and business-model similarity.

Signum Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ovesco Endoscopy
80%
W. L. Gore & Associates
76%
Raise Healthcare
76%

Signum Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 20, 2022
GrantApr 8, 2019
Series ANov 7, 2016

Key People

Founding team and executive leadership

Carol Burns

Chief Executive Officer

Executive Team

Signum Surgical Investors

Notable investors and investment history

Signum Surgical investors
InvestorRounds
InterTradeIrelandSeries A Extension
Western Development CommissionSeries A, Series A Extension
Invest Northern IrelandSeries A Extension
EIT HealthGrant
Enterprise IrelandSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 223% MoM, from 254 to 820.

  • Apr 25, 2026

    Monthly visitors increased 51% MoM.

Signum Surgical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Signum Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Signum Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIreland
Employee Range13
Year Founded2014
Last FundingSep 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?